Clinical Trials Directory

Trials / Unknown

UnknownNCT00463034

Genes That Affect Disease Progression in Women With Newly Diagnosed or Metastatic Breast Cancer

Genetic Factors Affecting Breast Cancer Progression

Status
Unknown
Phase
Study type
Observational
Enrollment
1,800 (estimated)
Sponsor
University of Sheffield · Academic / Other
Sex
Female
Age
Healthy volunteers
Not accepted

Summary

RATIONALE: Studying samples of blood and tumor tissue in the laboratory from patients with cancer may help doctors learn more about changes that occur in DNA and help doctors understand how patients respond to treatment. PURPOSE: This clinical trial is assessing how changes in genes affect disease progression in women with newly diagnosed or metastatic breast cancer.

Detailed description

OBJECTIVES: Primary * Correlate inherited and acquired variations in candidate genes with breast cancer progression and survival in women with newly diagnosed or metastatic breast cancer. Secondary * Establish a repository of blood and tumor samples from these patients, linked to a database of clinical, pathological, and treatment outcome data for future research studies. OUTLINE: Patients complete epidemiological questionnaires and undergo blood sample collection. Tumor tissue specimens are requested from the pathology departments. Blood samples are analyzed for single nucleotide polymorphisms and other polymorphic variants in candidate genes by polymerase chain reaction. Candidate genes include genes involved in the DNA damage response, programed cell death, inflammation, and angiogenesis. Tumor samples are analyzed by tissue microarrays using immunohistochemistry, denaturing high-performance liquid chromatography, and DNA sequencing to study genetic changes in the tumor. PROJECTED ACCRUAL: A total of 1,800 patients will be accrued for this study.

Conditions

Interventions

TypeNameDescription
GENETICmicroarray analysis
GENETICpolymerase chain reaction
GENETICpolymorphism analysis
OTHERhigh performance liquid chromatography
OTHERimmunohistochemistry staining method
OTHERlaboratory biomarker analysis
OTHERquestionnaire administration

Timeline

Start date
2005-04-01
Primary completion
2008-03-01
First posted
2007-04-19
Last updated
2013-12-18

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT00463034. Inclusion in this directory is not an endorsement.